NCT02869672

Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,200 (estimated)
• Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
• Sex: All
• Age: 2 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the safety and immunogenicity of the ACYW135 Meningococcal Polysaccharide Vaccine in population aged 2-50 years old. Subjects will be divided into 3 group according to their age, receiving the test vaccine and the control vaccine at the proportion of 1:1 randomly. Each age group has 400 subjects, 1200 in total.

Conditions

• ACYW135 Meningococcal Polysaccharide Vaccine

Interventions

Type	Name	Description
BIOLOGICAL	Tiantan Biology ACYW135 meningococcal polysaccharide vaccine	Tiantan Biology ACYW135 meningococcal polysaccharide vaccine, intramuscular injection, 0.5 ml
BIOLOGICAL	Hualan Biology ACYW135 meningococcal polysaccharide vaccine	Hualan Biology ACYW135 meningococcal polysaccharide vaccine, intramuscular injection, 0.5 ml

Timeline

• Start date: 2016-07-01
• Primary completion: 2016-12-01
• First posted: 2016-08-17
• Last updated: 2016-08-18